Last Updated: September 24, 2026

Intrabio Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INTRABIO

INTRABIO has one approved drug.

There are three US patents protecting INTRABIO drugs.

Summary for Intrabio

US Patents:	3
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Intrabio

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Intrabio	AQNEURSA	levacetylleucine	FOR SUSPENSION;ORAL	219132-001	Sep 24, 2024		RX	Yes	Yes	12,433,862	⤷ Start Trial				⤷ Start Trial
Intrabio	AQNEURSA	levacetylleucine	FOR SUSPENSION;ORAL	219132-001	Sep 24, 2024		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Intrabio	AQNEURSA	levacetylleucine	FOR SUSPENSION;ORAL	219132-001	Sep 24, 2024		RX	Yes	Yes	12,433,863	⤷ Start Trial				⤷ Start Trial
Intrabio	AQNEURSA	levacetylleucine	FOR SUSPENSION;ORAL	219132-001	Sep 24, 2024		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Intrabio	AQNEURSA	levacetylleucine	FOR SUSPENSION;ORAL	219132-001	Sep 24, 2024		RX	Yes	Yes	11,400,067	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Intrabio Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
New Zealand	790895	⤷ Start Trial
Hungary	E041914	⤷ Start Trial
China	121360107	⤷ Start Trial
Morocco	45615	⤷ Start Trial
South Korea	20240110078	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Intrabio Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3482754	50018/2026	Austria	⤷ Start Trial	PRODUCT NAME: LEVACETYLLEUCIN; REGISTRATION NO/DATE: EU/1/25/1928 (MITTEILUNG) 20260120
3482754	301377	Netherlands	⤷ Start Trial	PRODUCT NAME: LEVACETYLLEUCINE; REGISTRATION NO/DATE: EU/1/25/1928 20260220
3482754	C20260014	Finland	⤷ Start Trial
3482754	CR 2026 00020	Denmark	⤷ Start Trial	PRODUCT NAME: LEVACETYLLEUCIN; REG. NO/DATE: EU/1/25/1928 20260120
3482754	LUC50049	Luxembourg	⤷ Start Trial	PRODUCT NAME: LEVACETYLLEUCINE; AUTHORISATION NUMBER AND DATE: EU/1/25/1928 20260120
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.